16:15 EDT Krystal Biotech files to sell 1.73M shares of common stock for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on KRYS:
- Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of KB407 for the Treatment of Cystic Fibrosis
- Krystal Biotech doses first patient in Phase 1 trial of KB407
- Krystal Biotech price target raised to $160 from $130 at TD Cowen
- Krystal Biotech to Present at Upcoming Investor Conferences
- Biotech Alert: Searches spiking for these stocks today